French Chemicals Stock News

Recent performance snapshot Robertet (ENXTPA:RBT) has been on many watchlists after a year to date share price decline of about 10%, accompanied by negative returns over the past month and the past 3 months. See our latest analysis for Robertet. The 10.47% year to date share price decline, alongside a 12.35% fall in the 5 year total shareholder return, points to fading momentum as the market reassesses Robertet's growth outlook and risks. If you are comparing Robertet with other opportunities...

A lackluster earnings announcement from MGI Digital Technology Société Anonyme ( EPA:ALMDG ) last week didn't sink the...

If you are wondering whether EssilorLuxottica Société anonyme is attractively priced right now, starting with a clear view of its current valuation can help you frame that decision. The stock last closed at €171.40, with recent returns showing a 5.4% decline over 7 days, a 14.6% decline over 30 days, a 35.4% decline year to date, and a 27.6% decline over the past year, compared with a 35.5% return over 5 years. Recent coverage around EssilorLuxottica Société anonyme has focused on its role...

The subdued market reaction suggests that Crosswood SA's ( EPA:CROS ) recent earnings didn't contain any surprises...

A lackluster earnings announcement from Bilendi SA ( EPA:ALBLD ) last week didn't sink the stock price. However, we...

Key recent performance snapshot Engie (ENXTPA:ENGI) has drawn attention after a recent 0.5% daily gain, contrasted with a 3.8% decline over the past week and a 6.6% decline over the past month, despite a 5% gain in the past 3 months. For longer term holders, the stock shows a 17.5% return year to date and a 57.6% total return over the past year, with multi year total returns above 100%. This performance may prompt some investors to reassess their exposure. See our latest analysis for...

Ramsay Générale de Santé (ENXTPA:GDS) has reported H1 2026 revenue of €2.6b and a basic EPS loss of €0.31, with net income excluding extra items at a loss of €33.3m. The trailing twelve months show revenue of €5.3b and a basic EPS loss of €0.38 tied to a €41.2m net loss. Over recent halves, revenue has moved from €2.5b in H1 2025 to €2.6b in H1 2026. Basic EPS has remained in loss-making territory, ranging from a €0.39 loss in H1 2025 to a €0.33 loss in H2 2024 and a €0.31 loss in H1 2026,...

What recent performance suggests about ID Logistics Group ID Logistics Group (ENXTPA:IDL) has seen mixed share performance recently, with the stock down about 1.7% on the day and 3.3% over the past week, but slightly positive over the past month. Over the past 3 months, the stock shows a decline of around 14%, and the year to date return is roughly 13% lower, while the 1 year total return is also about 14% lower. See our latest analysis for ID Logistics Group. With the share price at...

Italian unions have called a strike targeting Kering in response to a reorganization plan and layoffs at Alexander McQueen. The action is focused on the group’s Italian operations, where many key activities in the luxury supply chain are based. The dispute highlights tensions between Kering’s restructuring efforts and worker concerns over job security and working conditions. The strike comes at a time when Kering, traded as ENXTPA:KER, is under close watch from investors. The share price...

Sanofi (ENXTPA:SAN) has been named the inaugural industry sponsor of the AlphaDetect initiative to advance early detection of Alpha-1 Antitrypsin Deficiency. The company is also working with Maze Therapeutics to improve Pompe disease outcomes through the use of Nexviazyme. These partnerships focus on rare respiratory and metabolic diseases, with an emphasis on earlier diagnosis and patient management. For readers tracking ENXTPA:SAN, these moves sit within Sanofi’s rare disease and...

As European markets navigate the complexities of stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index remains relatively stable, reflecting a cautious yet resilient economic environment. In this context, dividend stocks can offer investors a potential source of steady income and stability, particularly when broader market conditions are uncertain.

Legrand (ENXTPA:LR) has kicked off 2026 with Q1 revenue of €2.5b and basic EPS of €1.28, setting the tone for investors focused on how its earnings profile is evolving. Over the last year, the company has seen trailing twelve month revenue move from €8.6b to €9.7b and basic EPS lift from €4.45 to €4.91, giving you a clear sense of how the top and bottom lines have been tracking into this latest quarter. With net profit margins broadly steady, the focus now is on how these results align with...

It's been a good week for STMicroelectronics N.V. ( EPA:STMPA ) shareholders, because the company has just released its...

Arkema (ENXTPA:AKE) opened 2026 with Q1 revenue of €2.2b and basic EPS of €0.36, as investors weigh these fresh numbers against a trailing 12 month EPS of €0.23 on €8.9b of revenue and a net income of €17m that reflects thin profitability. Over the last year, a reported net profit margin of 0.2% and a large one off loss in the trailing figures have kept earnings in focus, while analysts in the dataset still see scope for earnings growth ahead. Overall, the latest quarter keeps attention...

Optimism over a potential resolution to the Middle East conflict is lifting expectations for international travel and luxury spending. This improved sentiment is feeding through to Hermès International Société en commandite par actions (ENXTPA:RMS) and the wider European luxury sector. Investors are reassessing demand prospects for high-end goods as travel dependent spending comes back into focus. Hermès shares last closed at €1,671.5, with the stock up 4.0% over the past week but showing...

If you are wondering whether L'Oréal's current share price reflects its true worth, you are not alone, especially with valuation tools often sending mixed signals. The stock most recently closed at €373.40, with returns of 2.1% over the past week, 4.2% over the past month, 2.4% year to date, 1.7% over 1 year, negative 5.7% over 3 years, and 16.9% over 5 years. Recent coverage of L'Oréal has focused on its position as a global beauty leader and how it is adapting product lines and marketing...

Wondering whether ABIVAX Société Anonyme at €110.20 is priced attractively or already reflecting a lot of optimism? This article walks through the key signals that matter for you as a shareholder or prospective investor. The stock has shown sharp moves, with a 17.9% return over the last 7 days, 8.7% over 30 days, a 4.2% decline year to date, and a very large 1-year return that is around 17x. These swings in the share price often reflect changing expectations about the company, its pipeline...

SEB stock in focus after recent gains SEB (ENXTPA:SK) has come into focus for investors after a recent share price move, with the stock up around 4% over the past week and over 20% in the past month. See our latest analysis for SEB. That short term momentum, including a 1 month share price return of 21.29% and a year to date share price return of 9.29%, contrasts with a 1 year total shareholder return decline of 32.74%, so recent strength is emerging against a weaker longer term record. If...

EssilorLuxottica Société anonyme (ENXTPA:EL) has just had its General Meeting approve a €4.00 per share dividend for the 2025 financial year, with investors also offered the option of receiving this payout in shares. See our latest analysis for EssilorLuxottica Société anonyme. That backdrop of shareholder friendly moves, including the dividend and recent share buybacks, comes after a year where the stock has lost momentum, with a 1-year total shareholder return decline of 25.78% despite a...

The European markets have shown a mixed performance, with the pan-European STOXX Europe 600 Index ending the week slightly up amid ongoing geopolitical tensions and economic uncertainties. Amid these broader market conditions, investors often look for opportunities beyond established names, and penny stocks can offer intriguing possibilities. While the term "penny stock" might seem outdated, it still signifies smaller or newer companies that can present unique opportunities. We've identified...

As the European market navigates a landscape marked by stalled negotiations in the Middle East and fluctuating oil prices, investors are keeping a close eye on opportunities that can provide stability and growth. In this environment, dividend stocks stand out as they offer potential income streams while contributing to portfolio diversification amidst economic uncertainties.

Sanofi (ENXTPA:SAN) has drawn fresh attention after new REMODEL Phase 4 data for Dupixent in eosinophilic esophagitis, with clinically meaningful improvements in esophageal function and structure compared with placebo at week 24. See our latest analysis for Sanofi. Despite the fresh Dupixent data and other recent updates, such as the planned Dynavax acquisition, the Toronto AI expansion and a higher ordinary dividend, Sanofi’s short term share price return has been weak, with longer term...

Investors may be wondering if Engie at €27.57 is still offering value after its strong run, or if most of the easy gains are already behind it. The stock has seen a 1.9% decline over the last 7 days and a 4.8% decline over the last 30 days, but its year-to-date return sits at 20.0%, with 57.4% over 1 year, 134.8% over 3 years and 247.1% over 5 years. Recent news coverage has focused on Engie as a major European utilities group, often highlighting its role in power generation, energy...

TotalEnergies has introduced its new Pangea 5 supercomputer, developed with Dell Technologies and NVIDIA. The system is designed to multiply the company’s computing power by six for subsurface imaging and AI driven research. Pangea 5 is configured to reuse waste heat to warm buildings at the research center, aiming to cut the carbon footprint of computing. TotalEnergies (ENXTPA:TTE) is adding heavy digital firepower with Pangea 5 at a time when the stock trades around €76.75 and has...